Media & Investors
Transparency is key at Kuros Biosciences. Explore essential information – from corporate documents to our current share price, all in one place.
Press releases
Here are our latest press releases.
For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.
Investor calendar
| Date | Event |
|---|---|
| Oct 16, 2025 | Trading Update Q3 2025 |
| Mar 10, 2026 | Earnings Release FY 2025 |
| Apr 14, 2026 | Trading Update Q1 2026 |
| Apr 15, 2026 | Annual Shareholders’ General Meeting 2025 |
| Aug 13, 2026 | Earnings Release HY1 2026 |
| Oct 15, 2026 | Trading Update Q3 2026 |
Reports, Corporate Governance & Meetings
Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.
Analysts
For more information regarding analyst reports, please contact:
Laura Pfeifer-Rossi
Octavian AG
sales@octavian.ch
Tel: +41 44 520 1588
Christophe Dombu
Kepler Cheuvreux
cdombu@keplercheuvreux.com
Tel: +33 1 53 65 35 78
Thomas Meyer
Baader Bank AG
tmeyer@helvea.com
Tel: +41 43 388 9265
Investor Relations
For more information regarding investor
relations, please contact:
Alexandre Müller
Kuros Biosciences
Investor Relations
IR@kurosbio.com
Tel: +41 43 268 32 31
Want to receive our press releases?